Drug Report History #275546

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-EN Version v1-EN
Language English English
Date Updated 2026-01-08 2026-01-08
Drug Identification Number 02546639 02546639
Brand name COLISTIMETHATE FOR INJECTION USP COLISTIMETHATE FOR INJECTION USP
Common or Proper name COLISTIMETHATE COLISTIMETHATE
Company Name MARCAN PHARMACEUTICALS INC MARCAN PHARMACEUTICALS INC
Ingredients COLISTIMETHATE SODIUM COLISTIMETHATE SODIUM
Strength(s) 150MG 150MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR
Packaging size 1X1 VIAL 1X1 VIAL
Additional packaging sizes
ATC code J01XB J01XB
ATC description OTHER ANTIBACTERIALS OTHER ANTIBACTERIALS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2026-01-08 2026-01-08
Actual start date 2026-01-08 2026-01-08
Estimated end date 2026-05-31 2026-05-31
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status No No
Company comments Shortage due to delay in manufacturing. Marcan Pharmaceuticals has inventory available but it is short dated. The expiry date on the product is June 30, 2026. Fresh batches are expected to arrive in May 2026 Shortage due to delay in manufacturing. Marcan Pharmaceuticals has inventory available but it is short dated. The expiry date on the product is June 30, 2026. Fresh batches are expected to arrive in May 2026
Health Canada comments